Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludarabine and TBI Conditioning for CML Transplant
NCT00119340Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Apr 2005
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine in chronic myeloid leukemia (CML), sponsored by Fred Hutchinson Cancer Center. Started Apr 2005; status: completed.
02
Drugs
fludarabine
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00119340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00119340.